- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02734914
Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure
Safety and Efficacy of Suctioning Flexible Ureteroscopy With Automatic Control of Renal Pelvic Pressure : A Clinical Randomized,Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi < 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result.
However, high perfusion rate leads to renal pelvic pressure increase, resulting in absorption of liquid, bacteria, and endotoxin into blood, followed by short-term complications such as systemic inflammatory response syndrome(SIRS , 8.1%), sepsis (0-4.5%), renal pelvic and ureteral tumor spread, and long-term complication of renal function impairment. Currently the commonly used flexible ureteroscope sheath (ureteral access sheath, UAS) reduces the renal pelvic pressure to a certain extent, but still can not control and monitor the renal pelvic pressure to reduce the incidence of complications, which, limit the clinical application of ureteroscopy.
Recently, the investigators present a novel technique of SF-URS with automatic control of renal pelvic pressure. In this study, transverse comparison is designed to evaluate the safety and efficacy of the suctioning flexible ureteroscopy with automatic control of renal pelvic pressure for the treatment of renal calculi.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject has provided informed consent and indicated a willingness to comply with study treatments
- Subject has a diagnosis of renal stones according to computer tomography (CT) results
- Subject is 18-75 yrs of age
- Subject has a single stone < 3 cm in size, or multiple stones < 3 cm in cumulative size
- Subject has a serum creatinine level within the normal range for the study center
Exclusion Criteria:
- The patient who do not agree with the intention of the clinical study.
- Subject needs bilateral procedures within one-stage ureteroscopy
- Subject has an active urinary tract infection (e.g., cystitis, prostatitis, urethritis, etc.) and severe hematuria
- Subject has been diagnosed with a urethral stricture or bladder neck contracture
- Subject has a disorder of the coagulation cascade system that would put the subject at risk for intraoperative or postoperative bleeding
- Subject is unable to discontinue anticoagulant and antiplatelet therapy preoperatively (3-5 d)
- Subject has other diseases and could not tolerate the endoscopic surgery
- Subject has any kind of anatomic abnormality of the urinary system that might have an influence on the surgery
- Subject has been diagnosed with hydronephrosis larger than 3 cm according to the B-scan ultrasonography examination
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SF-URS with automatic control of RPP
Participants in SF-URS with automatic control of renal pelvic pressure (RPP) group undergo ureteroscopy using the intelligent pressure control device (Medical irrigation and suctioning platform with pressure feedback function, and suctioning ureteral access sheath with function of pressure measuring).
|
A new F-URS monitoring and control of RPP using intelligent pressure control device
|
ACTIVE_COMPARATOR: conventional F-URS
Participants in conventional F-URS group undergo ureteroscopy using the classic flexible ureteroscope.
|
Ureteroscopy will be conducted using the ureteral access sheath from Cook Medical to treat renal calculi.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
stone-free rate
Time Frame: 4 weeks post-operatively
|
Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group *100%
|
4 weeks post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
stone-free rate
Time Frame: One day post-operatively
|
Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group *100%
|
One day post-operatively
|
Complication rates
Time Frame: Within 4 weeks after surgery
|
Number of participants undergo novel or conventional F-URS surgeries suffer complications associated with the surgery (i.e.
pain(NRS≥4), hematuria, T≥38℃, serum white blood cell≥12×〖10〗^9/L ,serum white blood cell<4×〖10〗^9/L, perforation, etc.)/Total number of participants in each group *100%
|
Within 4 weeks after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GanzhouHNU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Calculi
-
Amai Charitable TrustUnknown
-
Changhai HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsUnknown
-
Ningbo No. 1 HospitalThe First Affiliated Hospital with Nanjing Medical University; General Hospital... and other collaboratorsUnknownNephrolithiasis | Surgery--Complications | Urolithiasis | Renal CalculusChina
-
Institute for the Study of Urological Diseases,...CompletedRenal Insufficiency | Renal CalculiGreece
-
Tribhuvan University, NepalNot yet recruitingRenal Stone | Ureter Stone
-
Al-Azhar UniversityRecruiting
-
Ain Shams UniversityCompleted
-
Mansoura UniversityCompleted
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompleted
-
Seoul National University HospitalSK Telecom ConsortiumCompleted
Clinical Trials on SF-URS with automatic control of RPP
-
University of Missouri-ColumbiaSacred Heart Health SystemRecruiting
-
Hospital Clinic of BarcelonaSociedad Española de Neumología y Cirugía Torácica; Fondo de Investigacion...CompletedMechanical Ventilation | Ventilator-Associated PneumoniaSpain
-
Centre Hospitalier Universitaire de NīmesRoche Pharma AGCompletedMultiple Sclerosis | Clinically Isolated SyndromeFrance
-
University Hospital TuebingenActive, not recruitingInfant,PrematureGermany, United Kingdom, Netherlands, China
-
University Hospital, LilleCompleted
-
University of EdinburghNHS LothianTerminatedHypoxia | Obstetric Labor, Premature | Hyperoxia | Premature Infant | Oxygen TherapyUnited Kingdom
-
Southeast University, ChinaCompletedAutomatic Adjustmen of Inspiratory Triger and Cycling-offChina
-
University of EdinburghNHS LothianRecruitingHypoxia | Obstetric Labor, Premature | Hyperoxia | Premature Infant | Premature | Oxygen TherapyUnited Kingdom
-
Fisher and Paykel HealthcareUniversity Hospital, Angers; University Hospital, GrenobleCompletedInsomnia | Obstructive Sleep ApneaFrance
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingHealthy VolonteersFrance